Genomic Valley Biotech Ltd: Open offer
MR. PANKAJ GROVER has made an open offer for up to 26% of Genomic Valley Biotech Ltd at ₹30 a share.
Terms
Each figure links to its source- Offer price
- ₹30
- Shares sought
- 7,94,170
- Of voting capital
- 26%
- Trigger
- Took control
- Tendering opens
- 14 Dec 2026
- Tendering closes
- 28 Dec 2026
- SEBI observations
- Not known: Awaiting SEBI observations
- Competing offer
- No
- Acquirer
- MR. PANKAJ GROVER
- Dates marked expected are the latest the SAST Regulations allow from the last stated date.
Timeline
8 steps- Public announcement19 Oct 2026
- Detailed public statement27 Oct 2026
- Draft letter of offer filed with SEBIDate not yet stated
5 more steps, each with its date and filing. Free with a Google sign-in.
Sign in with GoogleSource documents
3 filings3 filings from the exchanges and SEBI, with links. Free with a Google sign-in.
Sign in with GoogleWhat this means for a shareholder
When someone acquires 25% or more of a listed company, or control of it, the SAST Regulations require them to offer to acquire at least a further 26% from public shareholders at a price no lower than the regulation’s floor.
The offer runs through a public announcement, a detailed statement, a draft letter with SEBI, SEBI’s observations, a ten-day tendering window and payment. If more is tendered than sought, acceptance is proportionate.
Updated 19:27 IST · Information from public filings. Not investment advice.